BioSpace News Archive

Business

Infinity Pharmaceuticals Provides 2019 Goals and Financial Guidance

IPI-549 Safety and Clinical Activity Support Initiation of Studies in Earlier Lines of Cancer Therapy with Double and Triple Combination Regimens

January 7, 2019
·
7 min read
Business

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

Advanced Energy Sales of approximately $4.4 to $4.5 million in Q4, up 43% to 47% year-over-year

January 7, 2019
·
6 min read
Drug Development

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases

Arrowhead Pharmaceuticals, Inc. announced that it has dosed the first subjects in a Phase 1 clinical study of ARO-ANG3, an RNAi-based investigational medicine targeting angiopoietin like protein 3 (ANGPTL3) being developed for the treatment of dyslipidemias and metabolic diseases.

January 7, 2019
·
5 min read
Business

Diplomat Partners With CSI Specialty Group to Expand Health System Services

The nation’s largest independent provider of specialty pharmacy services is partnering with CSI Specialty Group to provide specialty pharmacy solutions for hospitals and health systems.

January 7, 2019
·
4 min read
Business

PolarityTE Expands Contract Services Business with Addition of Jon Burrows

PolarityTE, Inc. announced the appointment of Jon Burrows, PhD as President of Contract Services and Senior Vice President of Corporate Development.

January 7, 2019
·
5 min read
Business

Eiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of Directors

Eiger BioPharmaceuticals, Inc. announced the appointment of Christine Murray, MS, RAC to its Board of Directors

January 7, 2019
·
2 min read
Biotech Bay

Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes

Pioneering Precision Medicine While Saving Healthcare Costs

January 7, 2019
·
6 min read
Biotech Bay

Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities

Completed productive initial interactions with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to discuss potential registration pathways for AT132 for the treatment of X-linked Myotubular Myopathy (XLMTM) and plan to provide additional details in Q1 2019

January 7, 2019
·
7 min read
Business

Silicon Valley Bank’s 2019 Healthcare Report Reveals Record Venture Investment in the U.S. and Europe

Investment Grew 50% over Previous Year Led by U.S. Biopharma

January 7, 2019
·
4 min read
Biotech Bay

Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection

Represents Successful Achievement of All 2018 Commercialization Milestones, on Path to 2019 Launch

January 7, 2019
·
7 min read